Exactly, mate well said. This guy’s off on a tangent marathon,...

Exactly, mate well said. This guy’s off on a tangent marathon, trying to win some points in a debate that doesn’t really matter. Let’s cut through the noise: the real issue is simple—some of these execs are getting paid way too much. That’s drained the company dry, forced a premature capital raise, and boom—sudden dilution at rock-bottom prices. And we’re not talking a little dilution here—this is 50-100%, we’ve just seen with CHM.

Glad to see some critical thinkers among the holders here. Just because you're invested in a company doesn't mean you have to sugarcoat everything. Pointing out the issues is how they get addressed—that's part of a shareholder's role, in my opinion.

I'm keeping a close eye on things. Hoping they can turn it around, but I'll wait for announcements that make a strong case for buying in. Interesting discussions and price action so far. Watching closely. Best of luck, everyone!